Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Safety of HAART use in pregnancy assessed at IAC

    • 21 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Vannappagari V, Albano J, Tilson H, Scheuerle A, Beckerman K, Seekins D, Storfer S, David N, Watts H.Monitoring birth defects among HIV-positive, ART exposed pregnant women: 20 years of antiretroviral pregnancy registry data. 18th International AIDS Conference: abstr. WEAX0104, 18 Jul 2010. Available from: URL: http://www.aids2010.org

    2. 2.

      Ford N, Mofenson L, Krazner K, Medu L, Frigati L, Mills E, Calmy A.Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts. 18th International AIDS Conference: abstr. WEAX0102, 18 Jul 2010. Available from: URL: http://www.aids2010.org

    3. 3.

      Siberry G, Williams P, Mendez H, G Seage III, Jacobson D, Hazra R, Rich K, Griner R, Tassiopoulos K, Kacanek D, Mofenson L, Watts DH, Pediatric HIV/AIDS Cohort Study.Safety of tenofovir use during pregnancy: associations with low birth weight and early growth in HIV-exposed uninfected infants. 18th International AIDS Conference: abstr. WEAX0103, 18 Jul 2010. Available from: URL: http://www.aids2010.org

    4. 4.

      Beckerman K, Albano J, Martinez-Tristani M, Seekins D, Storfer S, David N, Vannappagari V, Watts DH, Scheurle A, Tilson H.Preterm birth, low birth weight and fetal antiretroviral exposure: Gestational age and birth weight data from 10022 singleton live births reported to the Antiretroviral Pregnancy Registry 1989 through 31 January 2009. 18th International AIDS Conference: abstr. WEAX0105, 18 Jul 2010. Available from: URL: http://www.aids2010.org

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Safety of HAART use in pregnancy assessed at IAC. React. Wkly. 1315, 3–4 (2010). https://doi.org/10.2165/00128415-201013150-00005

    Download citation

    Keywords

    • Preterm Birth
    • Efavirenz
    • Neural Tube Defect
    • Tenofovir Disoproxil Fumarate
    • Infant Growth